NCT03279302View on ClinicalTrials.gov

Trial to Evaluate the PK Profile of Glepaglutide (ZP1848) After a Single IV and After Multiple SC Injections in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

September 4, 2017

Primary Completion Date

December 18, 2017

Study Completion Date

December 18, 2017

Conditions
Healthy Subjects
Interventions
DRUG

Glepaglutide

Solution for injection

Trial Locations (1)

75247

Covance CRU, Dallas

Sponsors

Lead Sponsor

Zealand Pharma
All Listed Sponsors
lead

Zealand Pharma

INDUSTRY

NCT03279302 - Trial to Evaluate the PK Profile of Glepaglutide (ZP1848) After a Single IV and After Multiple SC Injections in Healthy Subjects | Biotech Hunter | Biotech Hunter